07:25 AM EDT, 03/17/2025 (MT Newswires) -- Nurix Therapeutics ( NRIX ) said Monday that the US Food and Drug Administration has granted orphan drug designation to the company's experimental drug, bexobrutideq, for treating Waldenstrom macroglobulinemia, a type of blood cancer. The company said the drug is currently being evaluated in a phase 1 trial for adults with relapsed or...

07:26 AM EDT, 03/17/2025 (MT Newswires) -- GreenFirst Forest Products ( ICLTF ) over the weekend said its fourth-quarter loss doubled as sales dropped due to weather-related disruptions that slowed the company's supply chain. The company reported a fourth-quarter net loss from continuing operations of $26.6 million or $1.39 loss per diluted share, compared with a loss of $13.4 million...

07:22 AM EDT, 03/17/2025 (MT Newswires) -- Tesla (TSLA) is offering a free trial of its Full Self-Driving service in China, Reuters reported Monday, citing the company's Chinese website. According to the report, the free trial period starts Monday and extends through April 16. Tesla did not immediately respond to MT Newswires' request for comment. (Market Chatter news is derived...

March 17 (Reuters) - RENASANT CORP ( RNST ): * RENASANT AND THE FIRST ANNOUNCE RECEIPT OF REGULATORY APPROVALS FOR MERGER * RENASANT AND FIRST ANNOUNCE RECEIPT OF REGULATORY APPROVALS FOR MERGER * RENASANT CORP ( RNST ) - MERGER EXPECTED TO CLOSE ON APRIL 1, 2025 Source text: Further company coverage: ...